io Logo (WIPO, 09.07.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke io wurde als Bildmarke am 09.07.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Briefe, die eine besondere Form des Schreibens darstellen #Farben #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1568354 |
| Länder | 
|
| Basismarke |
Nr. UK00003458401,
15. Januar 2020
|
| Anmeldedatum | 09. Juli 2020 |
| Ablaufdatum | 09. Juli 2030 |
Markeninhaber
Pioneer House, Vision Park,
Histon
GB
Histon
GB
Markenvertreter
100 Hagley Road,
Edgbaston
GB
Waren und Dienstleistungen
01
Stem cells for research purposes; stem cells for scientific
purposes; stem cells other than for medical or veterinary
purposes; skeletal myocytes for research purposes; cortical
neurons for research purposes; biological tissue for
research and scientific purposes; biological tissue cultures
other than for medical or veterinary purposes; cultures of
cell media [other than for medical or veterinary use];
chemical reagents for use in biotechnology, other than for
medical or veterinary use; nutritive agents for processing
living cells [other than for medical use]; semi-processed
natural proteins for manufacturing food; proteins for use in
the manufacture of food products; proteins for use in
recombinant DNA technology [other than for medical use];
cell growth media, tissue culture media, cytokines,
antibodies, and reagents medical research use; cell
preparations for drug screening for research use;
genetically or otherwise modified cells for research use;
cells which are propagated, cultivated and expended in
bioreactors for research use
05
Cell therapeutics for medical and therapeutic use;
genetically or otherwise modified cells for medical,
therapeutic or clinical use; cells which are propagated,
cultivated and expanded in bioreactors for medical,
therapeutic or clinical use; cells for the purpose of tissue
regeneration; living cells for medical use; cells for
medical use; biological preparations for medical use;
diagnostic preparations for medical and/or veterinary
purposes; cell preparations for drug screening for medical,
therapeutic or clinical use; cell preparations for genetic
testing, screening for medical, therapeutic or clinical
purposes; stem cells for medical purposes; stem cells for
veterinary purposes; cell growth media, tissue culture
media, cytokines, antibodies, and reagents for medical or
diagnostic use; tissue culture media, growth factors, growth
media, serum, and nutritional supplements for in vitro
culturing, development, maintenance, expansion, assay or
manipulation of cells for medical, therapeutic or clinical
purposes; cell separation reagents for medical, therapeutic
or clinical purposes; dietary supplements; protein
supplements; nutrition supplements
09
Computer software and computer hardware for the separation
of biological and non-biological materials; bioinformatics
software; software for the control of laboratory robots;
software program and algorithm for medical, clinical,
research and biomanufacturing purposes; bioreactors;
bioreactors for biomanufacturing; bioreactors for research
use; bioreactor for cell culturing; bioreactors for
laboratory use; manufacturing software; smart manufacturing
system controls; electronic control units; laboratory
apparatus for magnetic cell separation; magnetic cell
separation laboratory equipment
29
Meat; meat substitutes; tissue engineered meat; synthetic
meat; cultured meat; laboratory-grown meat; fish, not live
40
Custom manufacture of biopharmaceuticals; processing of
biopharmaceutical materials for others; custom manufacture
of stem cells for research purposes, stem cells for
scientific purposes, stem cells other than for medical or
veterinary purposes, skeletal myocytes for research
purposes, cortical neurons for research purposes, biological
tissue for research and scientific purposes, biological
tissue cultures other than for medical or veterinary
purposes, cultures of cell media [other than for medical or
veterinary use], chemical reagents for use in biotechnology,
other than for medical or veterinary use, nutritive agents
for processing living cells [other than for medical use],
semi-processed natural proteins for manufacturing food,
proteins for use in the manufacture of food products,
proteins for use in recombinant dna technology [other than
for medical use], cell therapeutics, genetically or
otherwise modified cells, cells which are propagated,
cultivated and expanded in bioreactors, cells for the
purpose of tissue regeneration, living cells for medical
use, cells for medical use, biological preparations for
medical use, diagnostic preparations for medical and/or
veterinary purposes, cell preparations for drug screening,
cell preparations for genetic testing, screening, stem cells
for medical purposes, stem cells for veterinary purposes,
cell growth media, tissue culture media, cytokines,
antibodies, and reagents for medical, medical research or
diagnostic use, tissue culture media, growth factors, growth
media, serum, and nutritional supplements for in vitro
culturing, development, maintenance, expansion, assay or
manipulation of cells, cell separation reagents, magnetic
cell separation equipment, dietary supplements, protein
supplements, nutrition supplements, meat, meat substitutes,
tissue engineered meat, synthetic meat, cultured meat,
laboratory-grown meat and fish, not live
42
Biotechnology research; biotechnology testing; stem cell
research; synthetic biology services; stem cell biology
services; scientific services relating to the isolation and
cultivation of human tissues and cells; research and
development in the field of microorganisms and cells;
research and development in relation to genetic testing,
screening; research and development in relation to drug
screening; cell separation technology services; cell
separation research services; consultancy relating to
biotechnology; scientific and technological consultancy
relating to drug screening; scientific and technological
consultancy relating to genetic screening; scientific and
technological consultancy relating to cell therapy;
laboratory research; research on food; research and
development in the field of animal cells cultivated within
bioreactors; research in the reduction of carbon emissions
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 16. Februar 2023 | 2023/12 Gaz | BR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 14. September 2022 | 2022/40 Gaz | CA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 03. August 2022 | 2022/31 Gaz | UA | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 12. Juli 2022 | 2022/32 Gaz | AU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Juli 2022 | 2022/28 Gaz | MD | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 13. Juni 2022 | 2022/24 Gaz | TM | Ablehnung |
| 31. Mai 2022 | 2022/22 Gaz | MX | Ablehnung |
| 11. Mai 2022 | 2022/20 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. Mai 2022 | 2022/19 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 12. April 2022 | 2022/16 Gaz | BY | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 18. Februar 2022 | 2022/10 Gaz | KZ | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 08. Februar 2022 | 2022/9 Gaz | GE | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Januar 2022 | 2022/5 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 31. Dezember 2021 | 2022/1 Gaz | AM | Ablehnung |
| 30. Dezember 2021 | 2022/2 Gaz | VN | Ablehnung |
| 24. Dezember 2021 | 2021/52 Gaz | MD | Ablehnung |
| 02. Dezember 2021 | 2021/48 Gaz | JP | Ablehnung |
| 30. November 2021 | 2021/48 Gaz | NZ | Ablehnung |
| 24. November 2021 | 2021/48 Gaz | CH | Ablehnung |
| 10. November 2021 | 2021/46 Gaz | MY | Ablehnung |
| 29. Oktober 2021 | 2021/47 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 27. Oktober 2021 | 2021/43 Gaz | UA | Ablehnung |
| 15. Oktober 2021 | 2021/42 Gaz | NO | Ablehnung |
| 07. Oktober 2021 | 2021/42 Gaz | GE | Ablehnung |
| 03. Oktober 2021 | 2021/40 Gaz | KR | Ablehnung |
| 01. Oktober 2021 | 2021/40 Gaz | TJ | Ablehnung |
| 21. September 2021 | 2021/39 Gaz | BY | Ablehnung |
| 10. September 2021 | 2021/39 Gaz | KZ | Ablehnung |
| 07. September 2021 | 2021/37 Gaz | CA | Ablehnung |
| 27. August 2021 | 2021/35 Gaz | KG | Ablehnung |
| 17. August 2021 | 2021/34 Gaz | BR | Ablehnung |
| 02. August 2021 | 2021/31 Gaz | IL | Ablehnung |
| 16. Juni 2021 | 2021/24 Gaz | MN | Ablehnung |
| 22. Mai 2021 | 2021/21 Gaz | EM | Ablehnung |
| 31. März 2021 | 2021/15 Gaz | CN | Ablehnung |
| 25. Februar 2021 | 2021/9 Gaz | SG | Ablehnung |
| 10. Februar 2021 | 2021/7 Gaz | AU | Ablehnung |
| 28. Januar 2021 | 2021/4 Gaz | US | Ablehnung |
| 25. Januar 2021 | 2021/5 Gaz | IN | Ablehnung |
| 04. Januar 2021 | 2021/1 Gaz | Korrektur | |
| 09. Juli 2020 | 2020/51 Gaz | GB | Eintragung |
ID: 141568354